BL-B01D1 binds EGFR/HER3 on tumor cells, is internalized, and releases a topoisomerase I–inhibiting payload that causes DNA damage and apoptosis. Topoisomerase I is not the binding target; it is the intracellular enzyme inhibited after delivery.